These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17510377)

  • 1. Faithful companions: a proposal for neurooncology trials in pet dogs.
    Kimmelman J; Nalbantoglu J
    Cancer Res; 2007 May; 67(10):4541-4. PubMed ID: 17510377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically engineered models have advantages over xenografts for preclinical studies.
    Becher OJ; Holland EC
    Cancer Res; 2006 Apr; 66(7):3355-8, discussion 3358-9. PubMed ID: 16585152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous and genetically engineered animal models; use in preclinical cancer drug development.
    Hansen K; Khanna C
    Eur J Cancer; 2004 Apr; 40(6):858-80. PubMed ID: 15120042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging role of new transgenic mouse models in glioma research.
    Sonabend AM; Ulasov IV; Lesniak MS
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S7-13. PubMed ID: 18076321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of mouse glioma models in preclinical trials.
    Hu X; Holland EC
    Mutat Res; 2005 Aug; 576(1-2):54-65. PubMed ID: 16011838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of combined Ad5- delta 24RGD and radiation therapy in in vitro versus in vivo models of malignant glioma.
    Lamfers ML; Idema S; Bosscher L; Heukelom S; Moeniralm S; van der Meulen-Muileman IH; Overmeer RM; van der Valk P; van Beusechem VW; Gerritsen WR; Vandertop WP; Dirven CM
    Clin Cancer Res; 2007 Dec; 13(24):7451-8. PubMed ID: 18094429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of cytokine-induced killer cells in nude mouse xenograft model.
    Kim HM; Kang JS; Lim J; Kim JY; Kim YJ; Lee SJ; Song S; Hong JT; Kim Y; Han SB
    Arch Pharm Res; 2009 May; 32(5):781-7. PubMed ID: 19471894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using behavioral measurement to assess tumor progression and functional outcome after antiangiogenic treatment in mouse glioma models.
    Yang H; Chopp M; Zhang X; Jiang F; Zhang Z; Kalkanis S; Schallert T
    Behav Brain Res; 2007 Aug; 182(1):42-50. PubMed ID: 17572515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting epidermal growth factor receptor variant III: a novel strategy for the therapy of malignant glioma.
    Sonabend AM; Dana K; Lesniak MS
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S45-50. PubMed ID: 18076318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harnessing preclinical mouse models to inform human clinical cancer trials.
    Gutmann DH; Hunter-Schaedle K; Shannon KM
    J Clin Invest; 2006 Apr; 116(4):847-52. PubMed ID: 16585951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a preclinical model of spontaneous human melanoma central nervous system metastasis.
    Cruz-Munoz W; Man S; Xu P; Kerbel RS
    Cancer Res; 2008 Jun; 68(12):4500-5. PubMed ID: 18559492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dogs are man's best friend: in sickness and in health.
    Bentley RT; Ahmed AU; Yanke AB; Cohen-Gadol AA; Dey M
    Neuro Oncol; 2017 Mar; 19(3):312-322. PubMed ID: 27298310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphological and cytochemical analyses of two in vitro established spontaneous canine brain tumours].
    Dahme E; Müller B; Schröder B; Stavrou D
    Berl Munch Tierarztl Wochenschr; 1980 Jan; 93(2):21-7. PubMed ID: 7387613
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical trial trouble: did the right thing.
    Hill LR
    Lab Anim (NY); 2006 Jun; 35(6):15-6. PubMed ID: 16738581
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trial trouble.
    Lab Anim (NY); 2006 Jun; 35(6):15. PubMed ID: 16738582
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of chondrosarcoma animal models for assessment of adjuvant therapy.
    Clark JC; Dass CR; Choong PF
    ANZ J Surg; 2009 May; 79(5):327-36. PubMed ID: 19566512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in neuro-oncology: novel therapies and clinical trials.
    Lesniak MS
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S1. PubMed ID: 18076323
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical trial trouble: inform OLAW.
    McTighe M
    Lab Anim (NY); 2006 Jun; 35(6):16-7. PubMed ID: 16738583
    [No Abstract]   [Full Text] [Related]  

  • 20. The mighty mouse: genetically engineered mouse models in cancer drug development.
    Sharpless NE; Depinho RA
    Nat Rev Drug Discov; 2006 Sep; 5(9):741-54. PubMed ID: 16915232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.